Flexible Flow Meter Platform for OEM Product Development
Titan Enterprises announces the Hedgehog, an electronic development platform for OEM applications based upon the company's innovative Atrato ultrasonic flow meter.
The instrument has the capability of running up to four flow sensors simultaneously with real time analysis. The software interface permits a wide operating envelope allowing OEM products to be developed for 0.5–20-mm pipes including in-line and clamp-on devices. The structure is such that software changes can be simply “dragged and dropped” into a box in the interface permitting remote on-board logic updating and system re-programming. A full array of inlets and outlets are available including both analogue and high speed logic signals for fast response system requirements. Smaller single channel versions `Hoglets` have also been produced to enable testing of single pre-production meters where space may be at a premium.
Using patented technology that enables it to operate with excellent accuracy over very wide flow ranges, the Atrato range of inline flow meters is a genuine breakthrough in flow meter technology. Its rugged, clean bore construction makes the Atrato ideal for a wide range of low flow applications and its USB port allows software connectivity at literally the touch of a button. The advanced Atrato signal processing system permits flow measurement across the whole Reynolds number range allowing both viscous and non-viscous products to be metered anywhere.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.